Price T Rowe Associates Inc Legend Biotech Corp Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 11,165,584 shares of LEGN stock, worth $366 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,165,584
Previous 11,489,275
2.82%
Holding current value
$366 Million
Previous $509 Million
6.93%
% of portfolio
0.06%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Ra Capital Management, L.P. Boston, MA7.51MShares$246 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$218 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$188 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$165 Million1.16% of portfolio
-
Invesco Ltd. Atlanta, GA2.29MShares$75 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.49B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...